OS Therapies (OSTX) Stock Analysis: AI Score & Alternative Data
OSTX alt-data: Instagram followers climbing, web traffic lagging
Is OS Therapies a buy right now? The alternative data says hold. This OSTX stock analysis is built on the 25+ alternative data signals AltIndex tracks on OS Therapies every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 59/100: a Hold. The stock trades at $1.70 with a $80M market cap.
The bullish side of the 90-day ledger: Instagram followers up 10.8% to 92 followers, and sentiment up 24.4% to 97/100. The drag: web traffic down 44.9% to 15K monthly visits. That tension is what keeps the score mid-range.
OSTX’s broader alt-data profile also covers headcount (11 employees, according to LinkedIn), and Facebook followers (2K). Every signal links to its own page with full history, the OSTX technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on OSTX is just below.
OS Therapies AI Stock Analysis
OS Therapies is a biotech company focused on developing therapies for rare and orphan diseases. Their primary expertise lies in the development of immunotherapy treatments aimed at providing novel solutions for conditions with limited or no existing therapies.
Analysis generated September 3, 2026.
Recent OS Therapies Stock Alerts
|
OS Therapies | September 11 Price is down by -6% in the last 24h. |
|
OS Therapies | September 8 Price is up by 6.9% in the last 24h. |
|
OS Therapies | September 4 Price is up by 6% in the last 24h. |
|
OS Therapies | September 3 Price is up by 6.4% in the last 24h. |
OS Therapies Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 15K | 44.9% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 11 | 0% | |
| Sentiment | 97 | 24.4% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 14 | 600.0% | |
| Stocktwits Mentions | 182 | 420.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 3K | 15.4% | |
| X Followers | 418 | 8.0% | |
| Instagram Followers | 92 | 10.8% | |
| Facebook Followers | 2K | 0.5% | |
| Facebook Engagement | 31 | 47.6% |
About OS Therapies (OSTX)
OS Therapies Incorporated is a pioneering biopharmaceutical company dedicated to advancing innovative treatments for patients facing significant unmet medical needs, particularly within the neurological disorder domain. Leveraging its proprietary drug development technologies, the company is building a diverse and promising pipeline aimed at improving patient outcomes and quality of life. With a strong focus on research excellence and targeted therapeutic areas, OS Therapies presents a compelling opportunity for institutional investors looking to capitalize on transformative advancements in the dynamic biotech landscape.
| Price | $1.70 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $80M |
| Year Range | $1 – $2 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest OS Therapies News
View more → |
Osteosarcoma Market is Set to Rise by 2036 as 8 Emerging Therapies Set to Drive Future Growth | DelveInsightSeptember 3 - PRNewswire |
 |
Soft Tissue Sarcoma Market Set for Significant Growth at a CAGR of 7.9% During the Forecast Period (2026-2036), Driven by Novel Therapies and Expanding Treatment Landscape | DelveInsightJuly 15 - PRNewswire |
Saga plc initiated with bullish view at Berenberg, here's whyJuly 9 - Thefly.com |
|
 |
Soft Tissue Sarcoma with Lung Metastases Market Set to Expand Across the 7MM During the Forecast Period (2026-2036) with Advancing Targeted and Cellular Therapies | DelveInsightMay 26 - PRNewswire |
See OS Therapies’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for OSTX, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEOS Therapies Earnings & Financial Performance
View all earnings →OS Therapies Insider Trading Activity
View all →| Auerbach Shalom filed to sell 2,664,199 shares at $0.0. May 7 '25 |
| Auerbach Shalom filed to sell 2,746,199 shares at $0.0. Apr 10 '25 |
| Auerbach Shalom filed to sell 2,756,199 shares at $0.0. Apr 9 '25 |
| Auerbach Shalom filed to sell 2,431,211 shares at $0.0. Feb 14 '25 |
| Auerbach Shalom filed to sell 2,531,211 shares at $0.0. Jan 15 '25 |
OS Therapies Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to OS Therapies
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Kalaris TherapeuticsKLRS |
$3.30 2.4% | $79M | 50 |
 |
Aldeyra TherapeuticsALDX |
$1.37 6.2% | $81M | 64 |
 |
Verrica PharmaceuticalsVRCA |
$4.78 2.7% | $82M | 40 |
 |
IGM BiosciencesIGMS |
$1.28 1.9% | $77M | 41 |
 |
Sangamo TherapeuticsSGMO |
$0.07 57.5% | $83M | 37 |
Explore OS Therapies Data
Frequently Asked Questions: OS Therapies (OSTX)
OS Therapies has an AltIndex AI Score of 59/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
59/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of OS Therapies (OSTX) stock is $1.70 with a market cap of $80M.
As of today, OS Therapies’s PE (Price to Earnings) ratio is —.
View the latest OS Therapies insider transactions to see recent buying and selling activity by company executives and directors.
Check the OS Therapies congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The OSTX stock price chart above shows OS Therapies’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full OS Therapies technical analysis for RSI, moving averages, and more.
See the stocks similar to OS Therapies section on this page for companies in the same industry ranked by market cap and AI Score.
